Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and the Relationship Between Scan Status and Cognitive Decline
Public ClinicalTrials.gov record NCT01703702. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Multicountry Study to Evaluate the Effectiveness of Florbetapir (18F) PET Imaging in Changing Patient Management and to Evaluate the Relationship Between Florbetapir (18F) PET Scan Status and Cognitive Decline
Study identification
- NCT ID
- NCT01703702
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Avid Radiopharmaceuticals
- Industry
- Enrollment
- 641 participants
Conditions and interventions
Conditions
Interventions
- florbetapir (18F) Drug
Drug
Eligibility (public fields only)
- Age range
- 50 Years to 90 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2012
- Primary completion
- Mar 31, 2015
- Completion
- Mar 31, 2015
- Last update posted
- Aug 16, 2016
2012 – 2015
United States locations
- U.S. sites
- 21
- U.S. states
- 10
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Phoenix | Arizona | 85006 | — |
| Research Site | Phoenix | Arizona | 85054 | — |
| Research Site | Scottsdale | Arizona | 85258 | — |
| Research Site | Sun City | Arizona | 85351 | — |
| Research Site | Clearwater | Florida | 33756 | — |
| Research Site | Miami Beach | Florida | 33140 | — |
| Research Site | Orlando | Florida | 32806 | — |
| Research Site | West Palm Beach | Florida | 33407 | — |
| Research Site | Shreveport | Louisiana | 71130 | — |
| Research Site | Boston | Massachusetts | 02115 | — |
| Research Site | Chestnut Hill | Massachusetts | 02467 | — |
| Research Site | Quincy | Massachusetts | 02169 | — |
| Research Site | Las Vegas | Nevada | 89106 | — |
| Research Site | Las Vegas | Nevada | 89128 | — |
| Research Site | Patchogue | New York | 11772 | — |
| Research Site | Durham | North Carolina | 27710 | — |
| Research Site | Greensboro | North Carolina | 27405 | — |
| Research Site | Providence | Rhode Island | 02903 | — |
| Research Site | Providence | Rhode Island | 02906 | — |
| Research Site | Salt Lake City | Utah | 84108 | — |
| Research Site | Bennington | Vermont | 05201 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 36 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01703702, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 16, 2016 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01703702 live on ClinicalTrials.gov.